Significant association with location of central venous line placement and risk of venous thrombosis in children

Thrombosis and Haemostasis

Volumn 94, Issue 3, 2005, Pages 516-521

  Male, Christoph ^a   Julian, Jim A ^b   Massicotte, Patricia ^c   Gent, Michael ^b   Mitchell, Lesley ^c   Monagle, P ^d   Halton, J ^e   David, M ^f   Chalmers, E ^g   Krueger, M ^h   Werner, H ⁱ   Jacobs, B ^j   Pitcher, L ^k   Silva, M ^l   Guarini, L ^m   de Alarcon, P ⁿ   Luchtman Jones, L ^o   Razack, S ^p  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d Royal Children's Hospital   (Austria)

^e CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^f UNIVERSITY OF MONTREAL   (Canada)

^g ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^h UNIVERSITY OF FREIBURG   (Germany)

ⁱ UNIVERSITY OF KENTUCKY   (United States)

^j CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^k Royal Childer Hospital and District Health Service   (Austria)

^l KINGSTON GENERAL HOSPITAL   (Canada)

^m MAIMONIDES MEDICAL CENTER   (United States)

ⁿ UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^o ST LOUIS CHILDREN S HOSPITAL   (United States)

^p MONTREAL CHILDREN S HOSPITAL   (Canada)

more..

Author keywords

Central venous line; Children; Location; Risk factors; Venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN; REVIPARIN;

ADOLESCENT; ARTICLE; BRACHIAL ARTERY; BRACHIAL VEIN; CENTRAL VENOUS CATHETERIZATION; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; EQUIPMENT DESIGN; FEMALE; FEMORAL VEIN; HUMAN; INCIDENCE; INFANT; JUGULAR VEIN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATIENT MONITORING; PHLEBOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SUBCLAVIAN VEIN; VASCULAR ACCESS; VENOUS THROMBOEMBOLISM;

ADOLESCENT; AGE FACTORS; CATHETERIZATION, CENTRAL VENOUS; CHILD; CHILD, PRESCHOOL; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; RISK FACTORS; VENOUS THROMBOSIS;

EID: 24944563100     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH03-02-0091     Document Type: Article

References (36)

1. Andrew M, David M, Adams M et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994; 83: 1251-7.
2. Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995; 96: 939-43.
3. Nowak-Gottl U, von Kries R, Gobel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 1997; 76: F163-F167.
4. De Cicco M, Matovic M, Balestreri L et al. Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study. Thromb Res 1997; 86: 101-13.
5. Scholz G, Loewe KR. Die Punktion der Vena subclavia und ihre Komplikationen aus pathologisch-anatomischer Sicht. Med Welt 1969; 41: 2248-51.
6. Koksoy C, Kuzu A, Erden I et al. The risk factors in central venous catheter-related thrombosis. Aust N Z J Surg 1995; 65: 796-8.
7. Andrew M, Marzinotto V, Pencharz P et al. A cross-sectional study of catheter-related thrombosis in children receiving total parenteral nutrition at home. J Pediatr 1995; 126: 358-63.
8. Male C, Chait P, Andrew M et al. Central venous line-related thrombosis in children: association with central venous line location and insertion technique. Blood 2003; 101: 4271-8.
9. Trottier SJ, Veremakis C, O'Brien J et al. Femoral deep vein thrombosis associated with central venous catheterization: results from a prospective, randomized trial. Crit Care Med 1995; 23: 52-9.
10. Durbec O, Viviand X, Potie F et al. Lower extremity deep vein thrombosis: a prospective, randomized, controlled trial in comatose or sedated patients undergoing femoral vein catheterization. Crit Care Med 1997; 25: 1982-5.
11. Merrer J, De Jonghe B, Golliot F et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 2001; 286: 700-7.
12. Pippus KG, Giacomantonio JM, Gillis DA et al. Thrombotic complications of saphenous central venous lines. J Pediatr Surg 1994; 29: 1218-9.
13. Haire WD, Lieberman RP, Lund GB et al. Thrombotic complications of silicone rubber catheters during autologous marrow and peripheral stem cell transplantation: prospective comparison of Hickman and Groshong catheters. Bone Marrow Transplant 1991; 7: 57-9.
14. Mueller BU, Skelton J, Callender DP et al. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 1992; 10: 1943-8.
15. Couban S, Petrella MP, Egan B et al. Risk factors for central venous catheter-associated thrombosis in patients with cancer. Blood 2001; 98 (Suppl.): 267a.
16. Eastridge BJ, Lefor AT. Complications of indwelling venous access devices in cancer patients. J Clin Oncol 1995; 13: 233-8.
17. Trerotola SO, Kuhn-Fulton J, Johnson MS et al. Tunneled infusion catheters: increased incidence of symptomatic venous thrombosis after subclavian versus internal jugular venous access. Radiology 2000; 217: 89-93.
18. Cimochowski GE, Worley E, Rutherford WE et al. Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron 1990; 54: 154-61.
19. Beck C, Dubois J, Grignon A et al. Incidence and risk factors of catheter-related deep vein thrombosis in a pediatric intensive care unit: a prospective study. J Pediatr 1998; 133: 237-41.
20. Timsit JF, Farkas JC, Boyer JM et al. Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis. Chest 1998; 114: 207-13.
21. Grisoni ER, Mehta SK, Connors AF. Thrombosis and infection complicating central venous catheterization in neonates. J Pediatr Surg 1986; 21: 772-6.
22. Salonvaara M, Riikonen P, Kekomaki R et al. Clinically symptomatic central venous catheter-related deep venous thrombosis in newborns. Acta Paediatr 1999; 88: 642-6.
23. Joynt GM, Kew J, Gomersall CD et al. Deep venous thrombosis caused by femoral venous catheters in critically ill adult patients. Chest 2000; 117: 178-83.
24. Massicotte P, Julian JA, Gent M et al. An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. Thromb Res 2003; 109: 101-8.
25. Lensing AW, Buller HR, Prandoni P et al. Contrast venography, the gold standard for the diagnosis of deep-vein thrombosis: improvement in observer agreement. Thromb Haemost 1992; 67: 8-12.
26. Lensing AW, Prandoni P, Brandjes D et al. Detection of deep-vein thrombosis by real-time B-mode ultrasonography. N.Engl.J.Med. 1989; 320: 342-5.
27. Male C, Chait P, Ginsberg J et al. Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Thromb Haemost 2002; 87: 593-9.
28. Haire WD, Lynch TG, Lund GB et al. Limitations of magnetic resonance imaging and ultrasound-directed (duplex) scanning in the diagnosis of subclavian vein thrombosis. J Vasc Surg 1991; 13: 391-7.
29. McLaughlin K, Jones B, Mactier R et al. Long-term vascular access for hemodialysis using silicon dual-lumen catheters with guidewire replacement of catheters for technique salvage. Am J Kidney Dis 1997; 29: 553-9.
30. Karnik R, Valentin A, Winkler WB et al. Duplex sonographic detection of internal jugular venous thrombosis after removal of central venous catheters. Clin Cardiol 1993; 16: 26-9.
31. Horne MK III, May DJ, Alexander HR et al. Venographic surveillance of tunneled venous access devices in adult oncology patients. Ann Surg Oncol 1995; 2: 174-8.
32. Andrew M. Epidemiology of venous thromboembolic events. In: Andrew M, Monagle P, Brooker LA, editors. Thromboembolic Complications during Infancy and Childhood. Hamilton, London: BC Decker; 2000; 111-46.
33. Nowak-Gottl U, Dubbers A, Kececioglu D et al. Factor V Leiden, protein C, and lipoprotein (a) in catheter-related thrombosis in childhood: a prospective study. J Pediatr 1997; 131: 608-12.
34. Riordan M, Weiden PL. Factor V Leiden mutation does not account for central venous catheter-related thrombosis. Am J Hematol 1998; 58: 150-2.
35. Mitchell LG, Andrew M, Hanna K et al. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study. Cancer 2003; 97: 508-16.
36. Revel-Vilk S, Chan A, Bauman M et al. Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease. J Thromb Haemost 2003; 1: 915-21.